New cancer clinical trial: Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic Cancer

Published on: January 30, 2018 at 12:00PM
Condition:   Advanced Pancreatic Cancer
Intervention:   Drug: Nab-paclitaxel and S-1
Sponsor:   Aiping Zhou
Recruiting
http://ift.tt/2nnW9zr